[17] [18] This is a recognised caution for GLP-1 receptor agonist therapies (see semaglutide and tirzepatide UK SmPCs) and is likely relevant to retatrutide
While its not the same as Mounjaro, which also targets the GIP receptor, Wegovy injection is still considered a strong alternative and has shown similar results in numerous studies
Together, these details reduce uncertainty and help you focus on what brought you here in the first place: enjoyable, fair, and engaging sessions
However, some patients report slightly fewer gastrointestinal side effects with the oral form, possibly due to lower and more gradual absorption
Improved glycaemic control is the most common explanation for changes in urinary frequency
Always consult a qualified healthcare provider before starting any supplement regimen, especially if you are pregnant, nursing, taking medications (including GLP-1 receptor agonists), or have a medical condition